Previous 10 | Next 10 |
home / stock / dht.un:cc / dht.un:cc news
DRI Healthcare Trust to Host Fourth Quarter and Full Year 2022 Earnings Call and Webcast on March 2, 2023 Canada NewsWire TORONTO , Feb. 16, 2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today that it will hold a co...
DRI Healthcare Trust Announces US$95 million Private Placement of Preferred Securities and Increased Deployment Target Canada NewsWire Provides additional capital to fund biopharmaceutical research, driving value for DRI's unitholders and partners TORONTO , F...
DRI Healthcare Trust Declares Unit Distribution and Provides Update on Normal Course Issuer Bid Canada NewsWire TORONTO , Dec. 21, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced that, in accordance with the req...
DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) for the Treatment of Acid Sphingomyelinase Deficiency Canada NewsWire – Transaction adds another innovative rare disease therapy to DRI's ...
DRI Healthcare Trust Reports Third Quarter 2022 Results Canada NewsWire - Transactions for Empaveli, Zejula and Omidria royalties mark significant progress - - Cash receipts expected to be flat to slightly increasing through 2025 even with no further deployment...
DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 8, 2022 Canada NewsWire TORONTO , Oct. 25, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today it will hold a conference call ...
DRI Healthcare Trust Provides Update on Natpara Royalty Canada NewsWire TORONTO , Oct. 3, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced that, based on its ongoing review of its royalty entitlement on N...
DRI Healthcare Trust Announces Acquisition of a Royalty Interest in Zejula®, Currently Approved for the Treatment of Ovarian Cancer with Additional Indications Under Development Canada NewsWire – Zejula's multiple pipeline indications offer significant upsi...
DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences Canada NewsWire TORONTO , Aug. 4, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced that the Trust will participate in the foll...
DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 4, 2022 Canada NewsWire TORONTO , July 21, 2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") announced today it will hold a conference c...
News, Short Squeeze, Breakout and More Instantly...
Dri Healthcare Trust Company Name:
DHT.UN:CC Stock Symbol:
TSXC Market:
Dri Healthcare Trust Website:
DRI Healthcare Trust and DRI Capital Inc. Announce Executive Changes Canada NewsWire TORONTO , July 8, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") and DRI Capital Inc. ("DRI Healthcare"), the manager of the Trust, today announc...
DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 7, 2024 Canada NewsWire TORONTO , July 3, 2024 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") announces that it will hold a conference call to discuss its secon...
DRI Healthcare Trust Announces Acquisition of an Additional Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) for the Treatment of Acid Sphingomyelinase Deficiency Canada NewsWire – Transaction pushes total committed capital to over US$1 bill...